New issues and future legislation on biosafety.
The current debate on gene technology in Europe is reviewed with particular emphasis on the role of EFB and science in general. From this debate important lessons have been learned by scientists, industrial companies, legislators, parliamentarians and interest organisations. This gives confidence that the continued debate will eventually lead to public acceptance of gene technology even in the food area.
Novo Nordisk, Bagsvaerd, Denmark.
J
J
Mahler
D001709:Biotechnology / Q000331:legislation & jurisprudence; D005060:Europe; D005502:Food; D005818:Genetic Engineering / Q000331:legislation & jurisprudence